|
2022
|
Invention
|
Substituted 5-fluoro-1h-pyrazolopyridines and their use. The present application relates to novel... |
|
2021
|
Invention
|
Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-y... |
|
|
Invention
|
Process for preparing methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridi... |
|
|
Invention
|
Nanoformulations of methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-... |
|
2020
|
Invention
|
Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl... |
|
|
Invention
|
Process for manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholine. The present application relate... |
|
2019
|
Invention
|
Methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}... |
|
|
Invention
|
Process for preparing methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyr... |
|
|
Invention
|
Method of identifying a subgroup of patients suffering from dcssc which benefits from a treatment... |
|
|
Invention
|
Hydrates of substituted 5-fluoro-1h-pyrazolopyridines. The present application relates to a novel... |
|
|
Invention
|
Intermediates and process for preparing intermediates in the production of substituted pyrazolopy... |
|
2018
|
Invention
|
Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]py... |
|
2017
|
Invention
|
Crystalline substituted 5-fluoro-1h-pyrazolopyridines and process for preparing. The present appl... |
|
|
Invention
|
Process for preparing substituted 5-fluoro-1h-pyrazolopyridines. The present application relates ... |
|
2016
|
Invention
|
Substituted 5-flouro-1h-pyrazolopyridines and their use. The present application relates to novel... |
|
|
Invention
|
Substituted 5-fluoro-1h-pyrazolopyridines and their use.
The present application relates to nove... |
|
2014
|
Invention
|
Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectil... |
|
|
Invention
|
Forms of methyl methyl carbamate.
This present invention relates to forms of methyl {4.6-diamino... |
|
|
Invention
|
Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-y... |
|
2013
|
Invention
|
Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b] pyridin-3-yl]p... |
|
2012
|
Invention
|
Method for producing substituted 5-fluoro-1h-pyrazolopyridines. The present application relates t... |
|
2011
|
Invention
|
Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia an... |
|
|
Invention
|
Use of sgc stimulators, sgc activators, alone and combinations with pde5 inhibitors for the treat... |
|
|
Invention
|
The use of sgc stimulators, sgc activators, alone and combinations with pde5 inhibitors for the t... |
|
|
Invention
|
Substituted 5-fluoro-1h-pyrazolopyridines and use thereof. The present application relates to nov... |
|
|
Invention
|
Sgc stimulators or sgc activators alone and in combination with pde5 inhbitors for the treatment ... |
|
2010
|
Invention
|
Sgc stimulators or sgc activators in combination with pde5 inhibitors for the treatment of erecti... |
